Clinical Trial Update: Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer [Phase 2, Phase 3]

View source ↗

Summary

This document reports an ongoing phase 2/3 clinical trial evaluating anamorelin hydrochloride to reduce anorexia in patients with advanced non-small cell lung c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anorexia
• Non-small Cell Lung Cancer

Drugs mentioned

• Anamorelin hydrochloride (anamorelin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Anorexia, Lung Non-Small Cell Carcinoma | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING